Sustained complete response after maintenance therapy with topotecan and erlotinib for recurrent cervical cancer with distant metastases.
Case Rep Oncol
; 7(1): 97-101, 2014 Jan.
Article
in En
| MEDLINE
| ID: mdl-24575024
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Journal:
Case Rep Oncol
Year:
2014
Document type:
Article
Affiliation country:
Brazil
Country of publication:
Switzerland